Traumatic brain injury (TBI) has been suggested to increase the risk of amyotrophic lateral sclerosis (ALS). However, this link remains controversial and as such, here we performed experimental moderate TBI in rats and assessed for the presence of ALS-like pathological and functional abnormalities at both 1 and 12 weeks post-injury. Serial in-vivo magnetic resonance imaging (MRI) demonstrated that rats given a TBI had progressive atrophy of the motor cortices and degeneration of the corticospinal tracts compared with sham-injured rats. Immunofluorescence analyses revealed a progressive reduction in neurons, as well as increased phosphorylated transactive response DNA-binding protein 43 (TDP-43) and cytoplasmic TDP-43, in the motor cortex of rats given a TBI. Rats given a TBI also had fewer spinal cord motor neurons, increased expression of muscle atrophy markers, and altered muscle fiber contractile properties compared with sham-injured rats at 12 weeks, but not 1 week, post-injury. All of these changes occurred in the presence of persisting motor deficits. These findings resemble some of the pathological and functional abnormalities common in ALS and support the notion that TBI can result in a progressive neurodegenerative disease process pathologically bearing similarities to a motor neuron disease.
Introduction
The motor neuron diseases (MND) are a group of neurological disorders affecting motor neurons. Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is the most common form of MND (Lee et al. 2012) and is an inexorable neurodegenerative condition affecting one to two individuals per 100 000 annually (Robberecht and Philips 2013) . ALS is pathologically characterized by the death of both upper (motor cortex) and lower (brainstem and spinal cord) motor neurons, and the presence of ubiquitinated protein inclusions in surviving motor neurons that consist predominantly of transactive response DNA-binding protein 43 (TDP-43) (Neumann et al. 2006) . ALS cases can be either familial, which account for 5-10% of cases, or sporadic, which accounts for the remaining 90-95% of cases (Frakes et al. 2014) . Although several hereditary factors have been identified in familial ALS, the etiology of the majority of ALS cases is still poorly understood, but is hypothesized to involve a complex interaction of genetic and environmental risk factors including, among others, traumatic brain injury (TBI) (Chen et al. 2007; McKee et al. 2010; Schmidt et al. 2010) .
TBI is induced by biomechanical forces applied to the brain and represents a growing global health concern and socioeconomic problem (Roozenbeek et al. 2013) . It is a leading cause of death and disability in young adults, particularly males, in first world countries and the incidence continues to rise worldwide (Maas et al. 2008) . The brain injuries induced by TBI are often categorized as either primary or secondary injuries. Primary injuries are induced at the moment of impact and considered irreversible. Secondary injury processes are triggered by the primary insult, but continue to evolve in the minutes to years post-injury. TBI survivors often suffer from severe, chronic, and progressing neurologic disabilities, and TBI has been linked to the later development of numerous neurodegenerative conditions including chronic traumatic encephalopathy (McKee et al. 2009; Blennow et al. 2012 ), Alzheimer's-like dementia and Parkinsonism (Daneshvar et al. 2011) . Of particular relevance, a number of studies report an increased incidence of ALS in individuals with a history of TBI (Chen et al. 2007; Schmidt et al. 2010; Seals et al. 2016; Wang et al. 2016) . Schmidt et al. (2010) found that US veterans who had sustained a head injury involving loss of consciousness or medical care within the previous 15 years had an increased risk of ALS relative to veterans without head injuries. Further supporting a link between TBI and ALS, Chen et al. (2007) found not only a significantly higher risk of ALS in individuals who had sustained a head injury within the previous 10 years, but also that the risk was elevated more than 11-fold if they had suffered from multiple head injuries within this time (Chen et al. 2007 ). Additional evidence linking repeated brain traumas to ALS has also been found in studies of athletes and soldiers (Horner et al. 2003; Chiò et al. 2005; Weisskopf et al. 2005; Lehman et al. 2012) . For example, a cohort mortality study involving 3439 former National Football League players (i.e., professional American football) found an increased incidence of ALS mortality in these players compared with US population standardized mortality ratios (Lehman et al. 2012) . Moreover, motor neuron loss and corticospinal tract (CST) degeneration, which are consistent with the pathological features of ALS, have been observed in post-mortem brain samples of former athletes known to have suffered TBI and who experienced progressive motor function deterioration prior to death (McKee et al. 2010 ). Initial post-mortem studies in TBI sufferers have also identified a number of TDP-43 abnormalities. For example, McKee et al. (2010) found evidence of a TDP-43 proteopathy, including TDP-43-positive protein inclusions, in the brains and spinal cords of a subset of individuals with a history of TBI, while Johnson et al. (2011) reported increased phosphorylation-independent TDP-43 immunoreactivity in the cytoplasm during both the acute and chronic stages of a single more severe TBI. Furthermore, animal model studies indicate that TDP-43 undergoes proteolysis (Wang et al. 2015) and redistribution from the nucleus to the cytoplasm (Yang et al. 2014 ) after experimental TBI.
The above findings suggest that TBI might result in, or contribute to, an MND-like process. However, other studies have failed to find a relationship between TBI and ALS (Armon and Nelson 2012; Peters et al. 2013; Fournier et al. 2015) . Therefore, whether there is a direct link between TBI and the latter onset of ALS remains controversial, particularly given the many limitations and confounds associated with studying TBI and ALS in the clinical setting. Animal models allow for the control of such confounds and the investigation of causal relationships in neurological conditions that are not possible in human patients. As such, here we employed the commonly used and well-validated lateral fluid percussion injury (FPI) model of moderate TBI in the rat (Johnstone et al. 2015; Shultz et al. 2015) , along with advanced magnetic resonance imaging (MRI), molecular, immunohistochemical, and behavioral techniques to examine the relationship between TBI and ALS.
Materials and Methods

Subjects
Fifty-two male Long-Evans hooded rats were purchased from Monash animal research services (Melbourne, Australia). Rats were 12 weeks of age at the time of injury (i.e., young adults). Rats were housed individually under a 12-h light/dark cycle, and given access to food and water ad libitum for the duration of the experiment. All experimental procedures were approved by the Melbourne Health and Florey Institute of Neuroscience and Mental Health Animal Ethics Committees (AEC#1112173, 12-100-FNI) and were within the guidelines of the Australian code of practice for the care and use of animals for scientific purposes by the Australian National Health and Medical Research Council. Adequate measures were taken to minimize pain or discomfort.
Lateral FPI
As previously described (Shultz et al. 2013 , anesthetized rats underwent a 5-mm craniotomy centered −3 mm posterior and 4 mm lateral to Bregma (Paxinos and Watson 2005 ). An injury cap was then affixed to the skull over the window, filled with sterile silicon oil, and connected to the fluid percussion device. Body temperature was maintained at 37°C throughout surgery using a heat mat and a rectal thermometer (Shultz et al. 2014b . Anesthesia was then withdrawn, and at the first sign of hind paw withdrawal to a pinch test, rats received a fluid percussion pulse of 3 atm (n = 30 with 27% mortality rate) in order to induce a moderate TBI. Acute injury measures included duration of apnea, time to hind paw withdrawal to a pinch test (i.e., loss of consciousness), and time to self-righting (see Table 1 ). Upon resumption of spontaneous breathing, the injury cap was removed and the incision sutured. The protocol was identical for sham injuries but no fluid percussion pulse was given (n = 22). The rats were then assigned to either 1-week (TBI = 12, sham = 12) or 12-week (TBI = 10, sham = 10) recovery groups. The 1-week recovery groups underwent motor testing on day 7 post-injury before they were euthanized for tissue analysis. The 12-week recovery groups underwent serial MRI at 1 and 12 weeks post-injury, and motor function was assessed at 12 weeks post-injury before they were euthanized for tissue collection.
Motor Testing
The beam task was used to assess motor function on day 7 post-injury in the 1-week recovery group and the day prior to tissue collection in the 12-week recovery group (Bao et al. 2012) . Rats were trained on the beam on the day prior to beam task assessment. During the training session, rats were given five trials to traverse a 100-cm long beam with a width of 4 cm, and a further five trials to traverse a 100-cm long beam with a width of 2 cm. Beam testing occurred 24 h later and consisted of 10 trials on the 2-cm wide, 100-cm long beam. A maximum of 60 s was allowed for each trial and this was given to rats that fell. A video camera recorded each trial, and traverse time and the number of slips and falls were recorded.
MRI Acquisition
MRI scanning was performed using a 4.7-Tesla Bruker Avance III scanner with 30 cm horizontal bore as previously described (Johnstone et al. 2015; Shultz et al. 2015) . The scanning protocol consisted of a three-plane localizer sequence followed by multi-slice axial, coronal and sagittal images to accurately determine the orientation of the rat brain. T 2 -weighted images were acquired using a 2D Rapid Acquisition with Relaxation Enhancement (RARE) sequence with the following imaging parameters: repetition time (TR) = 10 000 ms; RARE factor = 8, effective echo time (TE eff ) = 36 ms; field of view (FOV) = 28.8 × 28.8 mm 2 ; matrix size = 192 × 192; number of slices = 80; isotropic spatial resolution = 150 × 150 × 150 μm 3 ; and number of repetitions (NR) = 2. Repetitions were averaged offline to improve the signal-to-noise ratio. Diffusion-weighted imaging (DWI) was performed using a single-shot 2D echo planar sequence with the following imaging parameters: TR = 9000 ms, TE = 37 ms, FOV = 38.4 × 38.4 mm 2 , partial parallel imaging acceleration = 2, matrix size = 128 × 128, number of slices = 36 and isotropic spatial resolution = 300 × 300 × 300 μm 3 . Diffusion weighting was performed with diffusion duration (δ) = 5 ms and diffusion gradient separation (Δ) = 14 ms in 126 non-collinear directions with 10 non-diffusion images (b 0 ) and b value = 1200 s/mm 2 .
Long-Evans Template Construction and CST Segmentation
A representative Long-Evans T 2 -weighted atlas was generated from a separate group of control rats (n = 10) using Advanced Normalization Tools (ANTs, http://stnava.github.io/ANTs/). Control rats had no surgery and underwent the same imaging protocol described above. ANTs derive an optimal template based on symmetric normalization that is unbiased by an individual rat's topographical idiosyncrasy (Avants et al. 2010 (Avants et al. , 2011 . A cross-correlation similarity metric was used due to its robustness to locally varying inhomogeneity .
To identify the CSTs, a diffusion tensor template was also constructed using DTI-TK (http://dti-tk.sourceforge.net), which derives an optimal template using the local fiber orientations to guide the alignment of white-matter tracts (Keihaninejad et al. 2013) . A second diffusion dataset with identical imaging parameters to those described above but with a stronger b value of 3000 s/mm 2 was used for whole-brain, constrained spherical deconvolution probabilistic tractography (MRtrix package, www.brain.org.au/software) (Tournier et al. 2007) . Each control rat's tractogram was then mapped into diffusion tensor template space using the DTI-TK derived deformation fields and the streamlines from all animals combined to form a whole-brain tractography template. The ipsilateral and contralateral CSTs were identified within the whole-brain tractography template and segmented using seed and target regions of interest (ROIs) positioned in the motor cortex and pons, respectively (Fig. 1A ). The resulting streamlines were then segmented and smoothed with a Gaussian filter and ITK-SNAP was used to manually terminate the resulting segmentations at the same point in the brainstem (Fig. 1B) (Yushkevich et al. 2006) .
MRI Analysis
Individual subject T 2 -weighted images were warped to the Long-Evans atlas using SyN (T 2 -to-atlas diffeomorphism) and a tensor-based morphometry (TBM) analysis of the CSTs was performed by calculating the log-Jacobian maps that quantify the local expansion (hypertrophy) and contraction (atrophy) of each voxel as its warped from the individual subject space to the template space ). In addition, the ipsilateral and contralateral motor cortices were outlined on the LongEvans atlas (Paxinos and Watson 2005) and the resulting ROIs transformed into individual space using the inverse T 2 -to-atlas diffeomorphisms for a priori volumetric analysis.
Diffusion tensor images (DTIs) were calculated using DTIFit, part of the FMRIB Diffusion Toolbox (FDT, http://fsl.fmrib.ox.ac. uk/fsl/fslwiki/FDT) and mapped to the Long-Evans diffusion tensor template using DTI-TK. Voxel-based analysis of fractional anisotropy (FA), radial diffusivity (RD), axial diffusivity (AD) and mean diffusivity (MD) within the CSTs was performed Table 1 Acute injury severity measures in rats given a sham injury or TBI and assigned to either 1-week or 12-week recovery groups (-mean ± SE, *P < 0.001).
Apnea (s)
Hind-limb (s) Self-righting ( using tract-based spatial statistics (TBSS, part of FSL) ). An individual blinded to the experimental injury conditions carried out all MRI acquisition and analysis.
Immunofluorescence
To assess neuronal loss and cytoplasmic TDP-43 in the motor cortex, 1-and 12-week recovery rats (n = 5-6/group) were transcardially perfused with PBS followed by paraformaldehyde (PFA). Brains were removed, post-fixed in PFA, paraffinembedded and sectioned at 8 μm on a paraffin microtome. Sections were then dewaxed and antigen retrieval was performed. Sections were then equilibrated in PBS (pH 7.4) for 10 min and blocked in 5% bovine serum albumin for 60 min at room temperature. 
Western Blotting
To assess levels of TDP-43 and phosphorylated TDP-43 (pTDP-43) in the motor cortex, fresh brain tissue was collected from a portion of the rats (n = 5-6/group) from both the 1-week and 12-week recovery groups. After prompt removal of the brains, the ipsilateral motor cortex was dissected, rapidly frozen in liquid nitrogen and stored at −80°C. The frozen tissue was ground on dry ice and solved in RIPA buffer containing 40 mM Tris (pH 7.5), 150 mM NaCl, 0.1% sodium dodecyl sulfate (SDS), 1% glycerol, 1% Triton X-100, 2 mM ethylene diamine tetraacetic acid (EDTA) and 0.5% NP-40 with protease and phosphatase inhibitors cocktail. The homogenate was composed of 1 mg of tissue/ mL RIPA buffer. The extracts were centrifuged at 12 000 × g for 15 min at 4°C and the supernatant was used for western blotting. After the protein concentration of supernatant was determined, the supernatant was mixed (5:1 (v/v) ratio) with sample buffer containing 300 mM Tris-HCl (pH 6.8), 30% 2-mercaptoethanol, 12% SDS, 0.005% bromophenol blue, and 20% glycerol. This mixture was boiled for 10 min at 95°C, centrifuged briefly, and stored at −20°C for western blot analysis. In all, 40 μg of protein was loaded for each well, the proteins in samples were separated with 12% SDS-polyacrylamide gel electrophoresis, and the bands of proteins were electroblotted onto polyvinyl difluoride (PVDF) membranes. The blots on PVDF were developed with rabbit anti-TDP-43 polyclonal (1:2000 dilution; Proteintech), rabbit anti-pTDP-43 polyclonal (1:1000 dilution; Cosmo Bio Co., Ltd) and mouse anti-β-actin monoclonal (1:5000 dilution; Sigma-Aldrich) antibodies, and visualized by enhanced chemiluminescent substrate kit and exposure to x-films. The mean intensity of the blots was quantified using Image J software (National Institutes of Health, USA). An experimenter blinded to experimental conditions conducted all western blot procedures.
Immunohistochemistry
The same rats from the 1-week and 12-week recovery groups that were perfused for immunofluorescence studies also had the lumbar sections of their spinal cords removed. Spinal cords were placed in 4% PFA for 24 h, and then cryopreserved in 30% sucrose. In all, 30 μm transverse sections were then serially cut with a cryotome. Slides were placed in 1:1 ethanol/chloroform overnight, and rehydrated through 100% and 95% ethanol to distilled water to reduce background fat staining. Sections were then placed in 0.1% cresyl violet for 10 min, rinsed in distilled water, dehydrated for 15 min in 95% ethanol, and mounted with DPX. A researcher blinded to experimental conditions conducted motor neuron counts as previously described (MorenoIgoa et al. 2010 ).
Ca 2+ Activation of Single Muscle Fibers
Fast-twitch extensor digitorum longus (EDL) muscles were excised from 1-and 12-week recovery rats, blotted on filter paper, tied to a capillary tube and immediately placed in a vial containing skinning solution of the following composition: potassium propionate, 125 mM; EGTA, 5 mM; ATP, 2 mM; MgCl 2 , 2 mM; imidazole, 20 mM; and glycerol volume fraction 50%, adjusted to pH 7.1 with 4 M KOH; and stored at −20°C for up to 12 weeks (Lynch et al. 2000) . Single permeabilized muscle fibers were isolated from the bundles, attached to a force sensitive transducer and activated by rapid immersion in buffered solutions of varying [Ca 2+ ] and [Sr 2+ ] as previously described (Williams et al. 1993 ).
RT-PCR
RNA was isolated from a 20-mg section of the EDL muscles using the Aurum Total RNA Fatty and Fibrous Tissue Kit (BioRad). Reverse transcription was performed from 1 µg of total RNA using the iScript cDNA Synthesis Kit (Bio-Rad). RT-PCR was used to compare atrogin-1 and m-calpain mRNA expression between EDL muscles of sham and TBI animals. β-2 microglobulin was used as an internal control gene. RT-PCR was performed using SoFast EvaGreen Supermix (Bio-Rad) on an iQ 96-well PCR system (Bio-Rad). Each amplification reaction contained 1 µl of cDNA (50 ng input RNA) and 300 nM of primer and was performed in triplicate. Thermal cycling conditions included initial denaturation at 95°C for 30 s, followed by 40 cycles of 95°C for 5 s and 55°C for 5 s. Melt curve analysis was performed post-cycling to confirm specificity of the amplified products. Relative quantification of atrogin-1 and m-calpain mRNA expression was determined using the 2 −ΔΔCt method.
Statistical Analyses
Voxel-wise analyses within the CSTs were performed using the FSL function "randomize" with 5000 permutations and fully corrected for multiple comparisons using threshold-free cluster enhancement (TFCE) (Nichols and Holmes 2002; Smith and Nichols 2009) . A mixed-design ANOVA (SPSS 21.0, IBM Corp), with injury (sham vs. TBI) as the between-subjects factor and time (1 week vs. 12 weeks) as the within-subjects factor, was used to assess motor cortex atrophy as measured with serial MRI. Two-way ANOVAs with injury (sham vs. TBI) and recovery time (1 week vs. 12 weeks) as the between-subjects factor were used to assess all other variables. Bonferroni post hoc comparisons were carried out as appropriate. Statistical significance was set at P < 0.05.
Results
TBI Induces Motor Deficits
Rats underwent testing on the beam task at either 1 or 12 weeks post-injury to assess motor function. Rats given a TBI displayed motor impairments compared with sham-injured rats, as indicated by a significant main effect for injury on the measures of slips and falls (F 1,40 = 48.482, P < 0.001; Fig. 2A ) and traverse times (F 1,40 = 32.193, P < 0.001; Fig. 2B ). There was no significant main effect for recovery time on either of the beam task measures (all P > 0.05). There were no statistically significant injury versus recovery time interactions on either of the beam task measures, although there was a non-significant trend on the number of slips and falls (P = 0.07).
TBI Induces Progressive Atrophy of the Motor Cortex
T 2 -weighted template images constructed using ANTs for each cohort at 1 week and 12 weeks reflect the progression of bilateral damage to the motor cortices of TBI rats (Fig. 3A) . ANOVA revealed significant injury versus time interactions for both ipsilateral (F 1,15 = 6.045, P < 0.05) and contralateral (F 1,15 = 8.529, P < 0.05) motor cortices. Post hoc analyses revealed no difference in ipsilateral (Fig. 3B ) and contralateral ( Fig. 3C ) motor cortex volumes at 1 week post-injury between TBI and shaminjured groups. Whereas at 12 weeks post-injury, rats given a TBI had significant reductions in both ipsilateral (P < 0.05) and contralateral (P < 0.05) motor cortex volume relative to shaminjured rats. There were also significant main effects found for injury (F 1,15 = 6.891, P < 0.05) and recovery time (F 1,15 = 6.046, P < 0.05) for the ipsilateral motor cortex.
TBI Results in Progressive Damage to the CSTs
TBM analysis revealed extensive volume loss throughout the ipsilateral CST and bilateral atrophy within the motor cortices of TBI rats 12 weeks post-injury. Figure 3D shows selected sagittal slices depicting the pattern of localized atrophy in the CSTs of TBI rats compared with sham-injured rats (P < 0.05, TFCE corrected). No significant regions of hypertrophy were identified and no differences were observed at 1 week post-injury. TBSS identified foci of reduced FA in the CSTs of TBI rats compared with sham-injured rats at 1 week post-injury ( Fig. 4A , P < 0.05, TFCE corrected). Regions included the ipsilateral corpus callosum, which also showed a corresponding, but more focal region of reduced AD, and the ipsilateral substantia nigra. TBSS analysis at 12 weeks postinjury identified a more widespread pattern of reduced FA that extended both anteriorly and posteriorly of those changes observed at 1 week and also included the contralateral corpus callosum, internal capsule, cerebral peduncle and pontine nuclei (Fig. 4B , P < 0.05, TFCE corrected). These regions were typically associated with an increase in RD after TBI with foci observed bilaterally in the corpus callosum and ipsilaterally in the internal capsule. Additionally, TBI rats had a small focus of increased MD in the anterior ipsilateral corpus callosum.
TBI Induces Neuronal Loss and Cytoplasmic TDP-43 in the Motor Cortex
The number of neurons in the motor cortex was measured using immunofluorescence staining. Examples of NeuNlabeled sections from sham and TBI rats are shown in Figure 5A . As indicated by a significant injury versus recovery time interaction (F 1,18 = 4.461, P < 0.05), rats given a TBI had significantly fewer neurons in the injured motor cortex compared with sham-injured rats at 12 weeks (P < 0.05, Fig. 5B ), but not 1 week, post-injury. There were also significant main effects found for injury (F 1,18 = 8.535, P < 0.01) and recovery time (F 1,18 = 12.752, P < 0.005).
The number of neurons with cytoplasmic TDP-43 was measured using double-label immunofluorescence staining. Examples of NeuN + TDP-43 co-labeled sections from sham and TBI rats are shown in Figure 5C . Rats given a TBI had significantly more neurons with cytoplasmic TDP-43 compared with sham-injured rats, as indicated by a significant main effect for injury (F 1,18 = 12.993, P < 0.005; Fig. 5D ). There was no significant main effect for recovery time or a significant injury versus recovery time interaction (all P > 0.05).
TBI Increases pTDP-43 Levels in the Motor Cortex
Levels of pTDP-43 and TDP-43 in the motor cortex were assessed using western blotting. Representative pTDP-43 western blots are shown in Figure 6A . ANOVA revealed a significant main effect for injury (F 1,18 = 12.804, P < 0.005; Fig. 6B ), with TBI rats having elevated expression of pTDP-43 in the motor cortex compared with sham-injured rats (P < 0.005). There was no significant main effect for recovery time or a significant injury versus recovery time interaction on the expression of pTDP-43 (all P > 0.05). There were no significant main effects or interaction on the expression of TDP-43 (all P > 0.05). Figure 2 . TBI induces motor impairments. Two-way ANOVA revealed a significant main effect for injury with rats given a TBI exhibiting (A) significantly more slips and falls, and (B) significantly longer traverse times on the beam task than sham-injured rats (mean + SE, *P < 0.001).
TBI Results in the Loss of Motor Neurons in the Spinal Cord
Examples of spinal cord sections from sham and TBI rats are shown in Figure 7A . As indicated by a significant injury versus recovery time interaction (F 1,18 = 4.784, P < 0.05), rats given a TBI had significantly fewer motor neurons in the spinal cord compared with sham-injured rats at 12 weeks (P < 0.05; Fig. 7B ), but not 1 week, post-injury. There were also significant main effects found for injury (F 1,18 = 5.235, P < 0.05) and recovery time (F 1,18 = 7.683, P < 0.05).
TBI Increases Markers for Muscle Atrophy
PCR analysis of rat EDL muscle tissue was performed to assess the relative gene expression of atrogin-1 and m-calpain, markers for muscle atrophy. As indicated by significant injury versus recovery time interactions (atrogin-1, F 1,21 = 8.325, P < 0.01; m-calpain, F 1,21 = 7.407, P < 0.05), rats given a TBI had significantly increased atrogin-1 mRNA (P < 0.01; Fig. 8A ) and mcalpain mRNA (P < 0.005; Fig. 8B ) compared with sham-injured controls at 12 weeks, but not 1 week, post-injury. There were also significant main effects found for injury (m-calpain, F 1,21 = 8.584, P < 0.01) and recovery time (atrogin-1, F 1,21 = 8.325, P < 0.01; m-calpain, F 1,21 = 7.409, P < 0.05). The Hill coefficient was also measured from excised single fibers from the EDL. ANOVA found a significant injury versus recovery time interaction (F 1,36 = 14.160, P < 0.001), with rats given a TBI having a significantly decreased Hill coefficient compared with shaminjured rats at 12 weeks (P < 0.05; Fig 8C) , but not 1 week, postinjury. There was also a significant main effect found for injury (F 1,36 = 10.102, P < 0.005).
Discussion
ALS is a progressive neurodegenerative disease characterized by loss of motor neurons in the motor cortex and spinal anterior horn, degeneration of the CST, TDP-43 pathologies, muscle atrophy, and motor dysfunction. A number of studies have linked a history of TBI to the later development of ALS; however, this relationship remains uncertain. Therefore, here we investigated whether experimental moderate TBI in the rat resulted in changes similar to those reported in ALS. Structural MRI and immunofluorescence analyses found evidence for progressive atrophy and neuronal loss in motor cortex that is consistent with previous studies reporting motor cortex volume loss (Chang et al. 2005; Kassubek et al. 2005; Turner et al. 2007; Canu et al. 2011; Senda et al. 2011 ) and cortical thinning (Agosta et al. 2009; Roccatagliata et al. 2009 ) in patients with ALS. DWI methods, which are sensitive to axonal injury (Pierpaoli et al. 1996; Le Bihan et al. 2001; Jones et al. 2013) , identified progressive CST damage in rats given a TBI. Further evidence of TBI-induced CST damage was provided by TBM analysis that identified significant bilateral atrophy of the CSTs 12 weeks after TBI. Rats given a TBI were also found to have increased phosphorylated and cytoplasmic TDP-43 in the motor cortex, fewer motor neurons in the anterior horn of the spinal cord, elevated expression of markers for muscle atrophy, and chronic motor impairments, all of which bear some resemblance to the cellular, structural, and functional changes observed in ALS.
TBI results in a complex and progressive pathophysiology that includes excitotoxic insult, apoptosis, oxidative stress, inflammation, proteopathies, and diffuse axonal injury (Blennow et al. 2012) . Each of these mechanisms have also been implicated in the pathogenesis of ALS (Kiernan et al. 2011) , and may have contributed to the motor cortex and CST degeneration, loss of spinal cord motor neurons, and motor impairments that we found post-TBI in rats. TDP-43 pathologies are of particular interest with regards to a possible mechanistic link between TBI and ALS. Specifically, TDP-43 pathologies are a hallmark of ALS (Lee et al. 2012) conditions, TDP-43 is known to regulate RNA pathways and is predominantly located in the nucleus (Lee et al. 2012) . However, when neurons are injured and/or stressed, as occurs in TBI, ALS, and other neuropathological settings, TDP-43 may redistribute to the cytoplasm as part of a stress response, and the phosphorylation of TDP-43 is postulated to play a role in this process (Lee et al. 2012) . Immunofluorescence analysis in this study found that rats given a TBI had more neurons in the motor cortex with cytoplasmic TDP-43 compared with shaminjured rats. Furthermore, western blotting identified elevated expression of pTDP-43 in the motor cortex of TBI rats compared with sham counterparts. Consistent with our findings here, previous studies have reported the redistribution of TDP-43 from the nucleus to the cytoplasm in post-mortem human TBI samples (McKee et al. 2010; Johnson et al. 2011) , as well as in rodent models of cortical impact and blast-wave induced brain injuries (Yang et al. 2014) .
Whether TDP-43 pathologies account for overt neuronal degeneration, and whether this contributed to the progressive brain damage found in the current study, remains to be determined. However, there is some evidence linking the cytoplasmic redistribution and phosphorylation of TDP-43 to neurodegeneration (Lee et al. 2012) . Numerous lines of evidence indicate that cytoplasmic TDP-43 has neurotoxic effects, although whether this is due to a toxic gain and/or loss of function remains to be determined (Lee et al. 2012) . For example, prolonged activity of stress granules consisting of cytoplasmic TDP-43 can increase cellular stress. This is detected by sensors in the endoplasmic reticulum that activate pathways that repress the synthesis of proteins vital to cell survival (Kim et al. 2014) . Calpain-and caspase-induced cell death, both of which are common in TBI, are closely associated with the presence of cytoplasmic TDP-43 in primary cortical neuron cultures (Yang et al. 2014) and may have triggered the cytoplasmic TDP-43 in rats given a TBI in our study. Interestingly, phosphorylated TDP-43 proteins have a longer half-life, which may inhibit degradation and thereby contribute to cytoplasmic aggregation (Lee et al. 2012) . Although future research is required to determine the full nature and causal role of TDP-43 abnormalities in the degenerative aftermath of TBI, it seems plausible that these changes are important contributors to secondary injury in TBI. Of note, the TBI-induced TDP-43 abnormalities in this study were present at 1 week post-injury, thereby preceding the majority of neurodegeneration that occurred in the TBI rats. Therefore, TDP-43 pathologies, and related pathways, may represent mechanisms that can be pharmacologically targeted in the early stages of TBI to mitigate the progressive and chronic consequences. Taken together, TDP-43 pathologies can occur in both ALS and TBI and represent a potential mechanistic link between the conditions that warrant further investigation.
Progressive degeneration of the CSTs is another pathological hallmark of ALS; thus, here we assessed CST integrity over the course of the study using serial in-vivo diffusion MRI. The diffusion measures of FA, RD, AD, and MD within the CSTs were analyzed using TBSS, a method combining the strengths of tractography and voxel-based methods to improve the robustness and sensitivity of diffusion analyses . We found sparse foci of reduced FA and AD in the ipsilateral CST of TBI rats 1 week after injury. However, by 12 weeks postinjury this had progressed into an extensive pattern of diffusion tensor changes, with bilateral reductions in FA and increased RD within the CSTs, after TBI. These findings are consistent with a progressive neurodegenerative disease and concur with earlier studies investigating water diffusion in patients with ALS (Cosottini et al. 2005; Hong et al. 2008; Ciccarelli et al. 2009; Sage et al. 2009; Agosta et al. 2010; Cosottini et al. 2010; Senda et al. 2011; Prudlo et al. 2012 ; rats. Enlarged panels show examples of TDP-43 localized to the nucleus (gray box), and cytoplasmic TDP-43 in TBI rat neurons (blue box). (D) TBI rats had significantly more neurons with cytoplasmic TDP-43 compared with sham-injured rats at both 1 and 12 weeks post-injury (mean + SE, *P < 0.005). (E) TBI rats also had an increased proportion of neurons with cytoplasmic TDP-43 compared with sham-injured rats at both 1 and 12 weeks post-injury (mean + SE, *P < 0.005). Scale bars = 50 μm. Zhang et al. 2014 ). There are a number of pathophysiological mechanisms that may have contributed to the progressive degeneration of the CSTs. It has been hypothesized that impaired axonal transportation of mitochondria to the distal axon, combined with mitochondrial dysfunction, results in deregulated energy metabolism, defective transport of other cargoes due to energy requirements, and the retrograde axonopathy observed in ALS (Rothstein 2009; Ferraiuolo et al. 2011) . There is also evidence to suggest that motor neurons are particularly vulnerable to AMPA-mediated excitotoxicity, which may account for distal axonal injury (Ferraiuolo et al. 2011 ). Furthermore, a progressive decline in both CST neurons and axons with age was reported for SOD1 G93A mice-the most common mouse model of ALS-using a retrograde tracer administered to the dorsal CSTs in the spinal cord (Zang and Cheema 2002) . While the pathogeneses of the observed diffusion changes are still a matter of debate, the overwhelming consensus is that they reflect the disruption and degeneration of the white matter in both ALS and TBI (Cosottini et al. 2005; Canu et al. 2011; Cirillo et al. 2012; Zhang et al. 2014; Shultz et al. 2014a ). Locomotor deficits (Gurney et al. 1994; Barnéoud et al. 1997; Fischer et al. 2004; Alves et al. 2011) , muscle atrophy (Atkin et al. 2005; Léger et al. 2006) , and spinal cord motor neuron loss (Gurney et al. 1994; Chiu et al. 1995; Alves et al. 2011 ) are well characterized in genetic models of ALS and are consistent with the loss of lower motor neurons and progressive failure of the neuromuscular system in ALS patients (Ueyama et al. 1998; Léger et al. 2006; Ravits et al. 2007 ). Therefore, our findings of long-term motor impairments on the beam task, loss of spinal cord motor neurons, and elevated levels of key markers of muscle atrophy provide further evidence of ALS-like pathology and functional deficits after TBI. Consistent with our findings, a recent study found that a mild TBI negatively affected muscle denervation and motor performance in mice, with the authors suggesting that a mild TBI may potentiate/influence the development of MND (Evans, et al. 2015 ). An FPI is known to affect the motor cortex, sensorimotor cortex (Johnstone et al. 2015) , and brainstem (McIntosh et al. 1989; Shima and Marmarou 1991) , all of which could contribute to the motor deficits. It is also interesting to speculate about the cause of the spinal cord pathology, which may be related to transneuronal degeneration (Anderson et al. 2009 ), although further studies are required to investigate this.
There are a number of limitations with the current study that should be considered. As alluded to earlier, more detailed analyses/characterization of TDP-43 pathologies in the brain and spine after TBI, as well as their contributions to neurodegeneration, must be completed. Related to this is the need to examine other pathological hallmarks of ALS in the context of TBI. For example, the presence of ubiquitinated protein inclusions in the brain and spinal cord, and whether ubiquitin was co-localized with TDP-43 was not investigated in this study but is a common feature of ALS (Lee et al. 2012) . Our analyses of neuronal loss and TDP-43 abnormalities were limited to the ipsilateral motor cortex, and future studies would benefit from examining these outcomes in other structures, including those in the contralateral hemisphere. The inclusion of additional post-injury timepoints would also be informative. For example, a more chronic post-injury timepoint (e.g., 1-2 years) might determine whether the relatively subtle ALS-like changes observed at 12 weeks post-TBI in this study progresses to the more severe pathology, symptoms and eventual mortality that is seen with ALS. Additional intermediate timepoints, as well as the inclusion of other motor tasks, would have allowed us to better characterize the progression and/or recovery of motor deficits. It is also important to note that while the current study focused on outcomes in the context of ALS, progressive and degenerative changes post-TBI are not unique to the motor system. For example, progressive atrophy of temporal lobe structures, such as the hippocampus and amygdala, have been reported post-TBI and are associated with long-term morbidities such as cognitive impairments and epilepsy (Kharatishvili et al. 2007; Shultz et al. 2013 Shultz et al. , 2015 . It is possible, however, that some structures and cell types are more vulnerable to TBI than others. Future research is required to investigate this, and how factors such as TBI location, injury mechanics, TBI severity, and number of TBIs (i.e., single vs. repeated) may influence these outcomes. Considering the broad and non-specific spectrum of neurological consequences that might occur in the aftermath of TBI, there is an emerging shift in philosophy regarding the classification of these effects (Washington et al. 2016) . Specifically, while TBI has traditionally been considered as a risk factor for other specific neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS, the emerging philosophy suggests that TBI be classified as a spectrum disorder that shares common characteristics with other neurodegenerative conditions with different etiologies (see Washington et al. 2016 for detailed review). It is also important to consider that most TBI survivors do not develop ALS, and that there are key differences in the progression of disease in the majority of ALS (i.e., rapid and terminal) versus TBI (i.e., potential for stabilization and rehabilitation) patients. Although future discussion and research into the specificity and/or classification of the chronic effects of TBI are required, the findings presented here indicate that TBI can induce consequences that resemble those occurring in MND.
In conclusion, in this study rats were administered a moderate TBI and assessed for the presence of MND-like pathological and functional abnormalities at 1 and 12 weeks post-injury. We found evidence indicating motor cortex atrophy, CST disorganization and degeneration, increased phosphorylated and cytoplasmic TDP-43, a loss of spinal cord motor neurons, muscle atrophy, and long-term motor impairments after TBI in rats. While future studies are required to further characterize the exact nature of these changes and identify the pathophysiological mechanisms that underlie them, our initial results provide evidence that experimental TBI can result in progressive long-term neurological consequences that resemble an MNDlike process. 
